FDA Grants Type B Meeting To Be Held November 8, 2010 To Discuss Phase III Protocols For Androxal(R)

Links shared publicly online about this topic.

  • 821
    total visits

FDA Grants Type B Meeting To Be Held November 8, 2010 To Discuss Phase III Protocols For Androxal(R)

medicalnewstoday.com —

Repros Therapeutics Inc.® (NasdaqCM:RPRX) announced that the Company has been granted a Type B meeting to be held on November 8, 2010 with the Division of Reproductive and Urologic Products to

View full resource at medicalnewstoday.com

Tags: Fertility, FDA, Urology

  • Share

Most Recently Shared on October 6, 2010 at 2:05 pm By:

mnt_drugapprov MNT Drug Approvals

FDA Grants Type B Meeting To Be Held November 8, 2010 To Discuss Phase III Protocols For Androxal(R) http://mnt.to/3KNx #regulatory

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Fertility News MNT Fertility News

MNT Men's Health MNT Men's Health

MNT Clinical Trials MNT Clinical Trials

Advertisement